Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 3/20 | 0.43 |
| ▸ | MMP1 | P03956 | 2/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | MMP13 | P45452 | 2/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | MMP7 | P09237 | 1/20 | 0.43 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28080723 | 1.00 | SLC1A3 (0.44) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL4755110 | 0.90 | SLC1A3 (0.40) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL6156149 | 0.90 | MMP9 (0.42) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL2770328 | 0.90 | SLC1A3 (0.40) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL17821130 | 0.86 | SLC1A3 (0.38) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL1869422 | 0.84 | MMP9 (0.45) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL4372757 | 0.84 | MMP9 (0.45) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL2325722 | 0.84 | MMP9 (0.45) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL8555153 | 0.83 | CYP2D6 (0.39) | SLC1A3SLC1A2SLC1A1GAAMMP9 | |
| SCHEMBL30829041 | 0.82 | TSHR (0.44) | SLC1A3SLC1A2SLC1A1MMP9MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087662-A1 | CHIRAL SALEN CATALYSTS AND METHODS FOR THE PREPARATION OF CHIRAL COMPOUNDS FROM RACEMIC EPOXIDES BY USING THEM | CHIROCHEM CO., LTD (KP) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087662-A1 | CHIRAL SALEN CATALYSTS AND METHODS FOR THE PREPARATION OF CHIRAL COMPOUNDS FROM RACEMIC EPOXIDES BY USING THEM | SRR, SQLE, EPHX1 | SLC1A3 4635/4885SLC1A2 4156/4885SLC1A1 4450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.